A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

NCT05159752 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Xeroderma Pigmentosum

Interventions

DRUG: Afamelanotide

Sponsor

Clinuvel Europe Limited